Let's Do Some Further Analysis of Stock Traded:
As of June 30, 2016, the OS was 11.7 billion shares
As of today, the AS is 16 billion shares
Let's assume that the OS right now is at 15.5 billion shares. Thus the amount of shares diluted between 7/1 and 1/27 is: 15.5-11.7 = 3.8 billion shares
Now the record shows that between 7/1/2016 and 1/27/2017, a total of 9.3 billion shares traded. Take the amount of shares diluted, it will leave us with 5.4 billion of undiluted shares traded among investors.
Let's Look at the Stock Market Value
On 6/30/2016 the stock pps was 0.001 with an OS of 11.6 billion shares. This translates to a Market Value of $11,600,000. The market value right now is $4,650,000. So, the stock right now lost 60% of its market value compared to June 30,2016.
Why the Market Value went Down
The stock fundamentals have improved significantly between 6/30/2016 and 1/27/2017. Significant discussion has taken place since then with the FDA and we are waiting now for decision by the FDA to clear the Actipatch OTC in the USA. That is a huge improvement for Biel.
While the fundamentals have improved significantly, the dark cloud over the SEC investigation scared a lot of people and that played a big role in shedding lots of shares between 6/30/2016 and 1/27/2017 on the order of 5.5 billion shares. Some of it for tax benefit and some of it a scare tactic and some of it a fear of the unknown.
Now the dark cloud is behind us and the SEC initial decision even it becomes final, it ultimately has no fundamental effect on Biel as Biel is still trading and it is still using dilution as a model to finance operation. Essentially, nothing changed. The good news is that the final decision on the SEC won't be issued anytime soon due to the SEC shortcoming on staff. In addition, even if the commission issued its final ruling, Biel can appeal the decision. Also, there is a question about the constitutionality of the administrative judges that is going to be for the supreme court to decide. Thus, this issue can take forever now to be enforced if any.
In conclusion, with Biel improved fundamentals and the SEC case is out of the way, there is nothing left but FDA OTC Clearance anytime soon. With all such positive events going forward, there is no place to go but Up Up and UP.
Such analysis is encouraging me to accumulate more clearly. The game played to bring the stock pps down is pretty much over, Biel Market Value is dirt cheap while on the verge of FDA OTC clearance OTC.Besies, the market value reduction Biel way outweigh the dilution
THINK ABOUT IT
AI
